USPTO serial 79289073
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $975
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cecilia R. Dickson
Cecilia R. Dickson The Webb Law Firm420 Fort Duquesne Boulevard, Suite 1200One Gateway CenterPittsburgh, PA 15222| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations for scientific use; diagnostic preparations for scientific use or for research; chemical preparations for use in scientific diagnosis; laboratory chemical preparations for scientific use; diagnostic preparations for scientific use; products for diagnosis for scientific use, namely, diagnostic reagents and assays; products for diagnosis intended for scientific use, namely, diagnostic reagents and assays; diagnostic reagents for scientific use; diagnostic reagents for in-vitro use for biochemistry, clinical chemistry and microbiology; diagnostic reagents for scientific use or for research; laboratory reagents for scientific use; universal reagents for automated laboratory testing systems; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical substances for laboratory use, other than for medical or veterinary purposes; chemicals for use in industry and science | ACTIVE | — |
| 005 | Biotechnological preparations for medical use, namely, reagent and assays for in vitro diagnostic; chemical preparations for medical use for blood analysis; diagnostic preparations for medical use; diagnostic preparations for medical or veterinary use; in-vitro diagnostic preparations for medical use; diagnostic kits consisting of medical diagnostic reagents and assays for testing bodily fluid; analytical reagents for medical use; chemical reagents for medical use; chemical reagents for medical diagnosis; diagnostic biomarking reagents for medical use; diagnostic reagents for medical use; clinical diagnostic reagents; reagents and substances for medical and veterinary diagnostic purposes; immunological reagents for medical use; reagents for analysis for medical use; reagents for medical diagnosis; reagents for diagnostic tests for medical use; reagents for in vitro use in laboratories for medical use; diagnostic substances for medical use; medical diagnostic reagents and assays for testing bodily fluids; diagnostic reagents for medical use sold as kits | ACTIVE | — |
| 010 | Medical diagnostic instruments in the nature of automated analyzers for body fluids for medical use; measuring apparatus for medical diagnostic use, namely, devices for measuring blood proteins, antibodies, enzymes, immunoglobulins, hormones and drugs; medical diagnostic apparatus for medical use, namely, blood testing apparatus, immunochemical testing apparatus; medical diagnostic testing apparatus for immunoassay procedures; blood testing apparatus for medical use; diagnostic apparatus for medical use, namely, medical diagnostic apparatus for the analysis of body fluids; testing apparatus for medical use, namely, blood testing apparatus, immunochemical testing apparatus; apparatus for analysis of substances for medical use, namely, apparatus for blood analysis for medical purposes; apparatus for conducting diagnostic tests for medical use, namely, medical diagnostic apparatus for the analysis of body fluids and for detecting antibodies; diagnostic apparatus for medical use, namely, medical diagnostic apparatus for the analysis of body fluids; diagnostic, testing and monitoring equipment, namely, medical diagnostic apparatus for analysis of body fluids and detecting and monitoring antibodies; medical diagnostic instruments for the analysis of body fluids; testing instruments for use in medical diagnosis, namely, blood testing apparatus, immunochemical testing apparatus; electrical instruments for medical use for blood diagnosis; medical diagnostic-test instruments for immunoassay procedures | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 25, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 7, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 27, 2025 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jan 31, 2025 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 11, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 16, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 31, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 11, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 17, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 17, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 25, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 25, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 15, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 9, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 9, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 24, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 24, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 17, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 3, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 3, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 3, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 3, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 3, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 28, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 28, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 28, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 18, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 17, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 17, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 17, 2020 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Dec 17, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 17, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 17, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 5, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 20, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 20, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 15, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 14, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 14, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 10, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 10, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 9, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |